Filter documents Clear search

pdf icon

FSRH CEU Statement: Management of women taking anticoagulants or antiplatelet medications who request intrauterine contraception or subdermal implants (March 2017)

File size: 292kb | Date: 1 March 2017 | Clinical Statements - PDF

This statement aims to encourage the consistent and safe management of women requesting intrauterine contraception (IUC) and subdermal implants (SDI) who are taking anticoagulants or antiplatelet medications. It is primarily aimed at clinicians working in primary care and community sexual and reproductive health clinics.

pdf icon

News item - Use of Nexplanon beyond three years - December 2016

File size: 110kb | Date: 4 December 2016 | Clinical Statements - PDF

A recently published multinational trial reports no pregnancies among 311 women who extended use of their existing Nexplanon® to four years and 204 women who continued to five years of use.[

pdf icon

CEU Statement: Contraception advice for individuals travelling to Brazil for the 2016 Olympics and their partners (revised 28 July 2016)

File size: 167kb | Date: 28 July 2016 | Clinical Statements - PDF

After reviewing the available body of evidence, the Centers for Disease Control (CDC) in the USA have concluded that a causal relationship exists between prenatal Zika virus infection and microcephaly and other serious brain anomalies. Cases of locally-transmitted Zika virus are still being reported in Brazil and most of its neighbouring countries.

pdf icon

FSRH CEU Statement: Response to the BMJ paper by Mao et. al. (October 2015)

File size: 44kb | Date: 1 October 2015 | Clinical Statements - PDF

A large observational study from the United States found that the risk of unintended pregnancy after Essure sterilisation was similar to that after surgical sterilisation. However just over 2% of women who had Essure sterilisation required a further operation related to the sterilisation procedure within a year.